Where Does the Money Go?
STOP CANCER is used to award research grants each year to a carefully selected group of young innovative scientists on the cutting edge of cancer research. This annual selection process of awardees is determined by a peer review program that follows the model used by the National Institutes of Health.
Each STOP CANCER Research Career Development Award (RCDA) grant is $150,000 which provides three years of research support for awardees. The number of grants awarded each year is determined by volume of donations.
Each of the prospective Comprehensive Cancer Centers where researchers carry out their work fund an additional “in-kind” like-amount of the RCDA
. The in-kind funding may include space, equipment, secretarial and administrative services, telephones, laboratory supplies, underlying salary support and other interactions between faculty and awardees. The value of every dollar that is contributed is doubled because of this in-kind matching commitment.
STOP CANCER funded research is the driving force behind discovery of live-saving drug therapies and approved clinical trials. Notable STOP CANCER awardee examples include Dr. Dennis Slamon’s research of a gene called HER-2 which resulted in a successful drug therapy for breast cancer, Herceptin, used world-wide; Dr. Charles Sawyers’ research which led to the development of Gleevec, the primary drug therapy for chronic myeloid leukemia
, and Dr. Karen Aboody’s stem cell
research which has received FDA clinical trial approval for a type of brain cancer therapy.
The broad range of STOP CANCER research funding includes breast and ovarian cancer, lymphoma
, colon cancer, pediatric cancers, brain cancer, skin cancer and prostate cancer, as well as stem cell
and genetic engineering studies.
STOP CANCER does not differentiate against any types of cancer and/or treatments; therefore, all promising research is considered when selecting awardees.
STOP CANCER Donor Naming Opportunities
STOP CANCER’S Research Career Development Awards and Seed Grant
s may be designated in memory of, or in honor of, a person or persons or a company or organization.
The Donor may select the institution and/or the researcher to receive the Award, Grant or Endowment Chair; namely, UCLA’s Jonsson, USC’s Norris or City of Hope Comprehensive Cancer Center, all funded by STOP CANCER.
The Donor is invited to meet with the scientist/recipient of the donation as well as tour the laboratories where the relevant cancer research is conducted.
The Endowed Chair Donor also becomes an integral part of the Chair Holder’s credentials. A formal presentation is held at the recipient’s medical center.
Seed Grant - $ 25,000 per year
Research Career Development Award - $150,000 over three years
Endowed Chair - $1 million commitment